APOE and dementia: As expected, the MCI and dementia groups both showed worse performance scores in the neuropsychological tests and higher proportions of APOE ε4 carriers than the NC group (all p < 0.001); the AD CSF core biomarkers were also more altered in these two groups than in the NC group (all p < 0.001).